Axxcess Wealth Management LLC Sells 1,011 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Axxcess Wealth Management LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 35.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,876 shares of the medical equipment provider’s stock after selling 1,011 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Intuitive Surgical were worth $377,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of ISRG. RB Capital Management LLC raised its stake in shares of Intuitive Surgical by 4.4% during the 1st quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock worth $523,000 after acquiring an additional 73 shares in the last quarter. IFM Investors Pty Ltd grew its position in Intuitive Surgical by 25.6% during the 1st quarter. IFM Investors Pty Ltd now owns 60,188 shares of the medical equipment provider’s stock worth $18,158,000 after purchasing an additional 12,269 shares during the last quarter. DAVENPORT & Co LLC grew its position in Intuitive Surgical by 10.2% during the 1st quarter. DAVENPORT & Co LLC now owns 1,071 shares of the medical equipment provider’s stock worth $323,000 after purchasing an additional 99 shares during the last quarter. Waldron Private Wealth LLC grew its position in Intuitive Surgical by 11.4% during the 1st quarter. Waldron Private Wealth LLC now owns 1,724 shares of the medical equipment provider’s stock worth $520,000 after purchasing an additional 176 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its position in Intuitive Surgical by 0.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider’s stock worth $133,012,000 after purchasing an additional 3,982 shares during the last quarter. Institutional investors own 82.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on ISRG shares. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $250.00 to $260.00 and gave the stock a “buy” rating in a research report on Friday, September 9th. Jefferies Financial Group started coverage on shares of Intuitive Surgical in a research report on Wednesday, October 12th. They set a “hold” rating and a $210.00 target price on the stock. Morgan Stanley boosted their target price on shares of Intuitive Surgical from $215.00 to $235.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 19th. Wells Fargo & Company dropped their target price on shares of Intuitive Surgical from $265.00 to $248.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 19th. Finally, The Goldman Sachs Group dropped their target price on shares of Intuitive Surgical from $319.00 to $273.00 and set a “buy” rating on the stock in a research report on Friday, July 29th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $261.05.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $264.45 on Thursday. The company’s fifty day moving average price is $219.05 and its 200 day moving average price is $216.96. Intuitive Surgical, Inc. has a 1 year low of $180.07 and a 1 year high of $369.21. The company has a market capitalization of $93.45 billion, a PE ratio of 69.78, a price-to-earnings-growth ratio of 5.79 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last announced its quarterly earnings results on Tuesday, October 18th. The medical equipment provider reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.07. Intuitive Surgical had a net margin of 22.52% and a return on equity of 11.54%. The firm had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same period in the prior year, the firm posted $1.04 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. On average, equities analysts expect that Intuitive Surgical, Inc. will post 3.79 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 8,000 shares of the company’s stock in a transaction on Friday, October 21st. The shares were sold at an average price of $209.78, for a total transaction of $1,678,240.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares in the company, valued at $45,522.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $210.76, for a total value of $1,343,595.00. Following the completion of the sale, the director now directly owns 11,224 shares in the company, valued at $2,365,570.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 8,000 shares of the stock in a transaction dated Friday, October 21st. The shares were sold at an average price of $209.78, for a total transaction of $1,678,240.00. Following the completion of the sale, the executive vice president now owns 217 shares of the company’s stock, valued at $45,522.26. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 72,953 shares of company stock worth $15,867,996. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.